Repeat Revascularization Is a Faulty End Point for Clinical Trials
Author:
Affiliation:
1. From the Stanford University School of Medicine, Stanford, CA.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Link
https://www.ahajournals.org/doi/pdf/10.1161/CIRCOUTCOMES.112.965764
Reference7 articles.
1. Does angiography six months after coronary intervention influence management and outcome?
2. The Clinical Impact of Routine Angiographic Follow-Up in Randomized Trials of Drug-Eluting Stents
3. Trial and Error
4. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
5. Quality of Life after PCI with Drug-Eluting Stents or Coronary-Artery Bypass Surgery
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessment of Repeat Revascularization in Percutaneous Coronary Intervention Randomized Controlled Trials as a Surrogate for Mortality: A Meta-Regression Analysis;Current Problems in Cardiology;2023-04
2. Plato's allegory of the cave and the paradigm of complete revascularization in STEMI;Clinical Cardiology;2022-12-20
3. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease;JACC: Cardiovascular Interventions;2020-02
4. Limitations of Repeat Revascularization as an Outcome Measure;Journal of the American College of Cardiology;2019-12
5. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease;New England Journal of Medicine;2019-11-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3